Inter Organ Crosstalk in Non-Alcoholic Steatohepatitis (NASH)
joint with Adipose Tissue and Metabolic Health
Scientific Organizers: Greg Steinberg, Camilla Charlotte Schéele and Saswata Talukdar
Date: February 06 - 09, 2022
|InPerson Location: Keystone Resort, Keystone, CO, USA|
|Meeting is available as a Livestream, click register button below for more details|
|Meeting is available to view On Demand, click register button below for more details|
For Updated Health and Safety Guidelines for Keystone Symposia in-person meetings, click here
The epidemics of obesity and type 2 diabetes are driving the development of non-alcoholic steatohepatitis (NASH) which is rapidly accelerating rates of liver cirrhosis and hepatocellar carcinoma (HCC). NASH is characterized by complex crosstalk between different cell types and organ systems that leads to steatosis, inflammation and fibrosis. This intracellular communication involves multiple cells types within the microenvironment (e.g. stellate cells, macrophages, t-cells and hepatocytes) but also includes interactions with multiple organ systems (e.g. gut microbiome, brown/beige/white adipose tissue and muscle). With the development of many new technological advances (e.g. proteomics, single cell RNAseq, organoids) our understanding of these intricate signaling pathways is rapidly expanding. The primary aim of this meeting is to bring scientists across different disciplines together to provide a forum for sharing rapidly emerging methodological advances in order to understand the mechanisms by which cells and organ systems communicate, in order to develop new paradigms and therapeutic strategies for the treatment of NASH. Given the importance of adipose tissue as a critical storage depot, an endocrine organ, and a regulator of energy expenditure, hosting this meeting with one focused on adipose tissue function will expand opportunities for interdisciplinary interactions.
Global Health Award Deadline: January 17 2022 details
Scholarship Deadline: October 20 2021 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.
All those submitting an abstract should plan to attend in-person to ensure extensive interaction opportunities. At this time we recognize that a small percentage of submitters may be unable to travel due to border crossing restrictions and/or institutional travel bans. If these restrictions are still in place during the meeting, permissions for remote presentations will be given for the exceptional circumstances listed above.
NOTE: In the event that your abstract isn't selected for a short talk and you're not able to travel the abstract fee is nonrefundable. All paid abstracts will be included in the meeting app and meeting materials available online.
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1 R13 DK131814-01
Funding for this conference was made possible (in part) by 1 R13 DK131814-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.